According to Myriad Genetics's latest financial reports the company's current revenue (TTM ) is C$1.19 Billion. an increase over the revenue in the year 2023 that were of C$0.99 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | C$1.20 B | 20.31% |
2023 | C$0.99 B | 8.52% |
2022 | C$0.92 B | 4.59% |
2021 | C$0.88 B | |
2019 | C$1.06 B | -2.16% |
2018 | C$1.08 B | 13.03% |
2017 | C$0.96 B | -4.8% |
2016 | C$1.00 B | -2.58% |
2015 | C$1.03 B | 23.13% |
2014 | C$0.84 B | 7.21% |
2013 | C$0.78 B | 44.7% |
2012 | C$0.54 B | 20.32% |
2011 | C$0.45 B | 19.57% |
2010 | C$0.37 B | 3.7% |
2009 | C$0.36 B | -22.6% |
2008 | C$0.46 B | 145.87% |
2007 | C$0.19 B | 23.8% |
2006 | C$0.15 B | 34.53% |
2005 | C$0.11 B | 46.49% |
2004 | C$78.28 M | 1.24% |
2003 | C$77.32 M | -17.99% |
2002 | C$94.29 M | 20.66% |
2001 | C$78.14 M | 25.25% |
2000 | C$62.39 M | 48.34% |
1999 | C$42.06 M | 16.41% |
1998 | C$36.13 M | 19.28% |
1997 | C$30.29 M | 148.48% |
1996 | C$12.19 M |